RHUMBLINE ADVISERS - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,776
-27.1%
1,8300.0%0.00%
Q2 2023$6,551
-97.8%
1,830
-94.6%
0.00%
Q1 2022$294,000
-15.8%
34,046
+39.3%
0.00%
Q4 2021$349,000
-28.5%
24,435
+10.0%
0.00%
-100.0%
Q3 2021$488,000
+161.0%
22,223
+58.9%
0.00%
Q2 2021$187,00013,9820.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
Belvedere Trading LLC 40,690$343,0000.01%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders